Direct expression of antibodies

作者: Andrew Geall , Todd Suscovich , Galit Alter

DOI:

关键词:

摘要: The present invention relates to methods exogenous nucleic acid molecules, such as RNA, that encode an antibody or antigen-binding fragment of antibody, and optionally a cellular modulation factor and/or potentiation factor. is results in increased expression the fragment. provides desired effector other properties. molecules can be DNA mRNA (including self-replication RNA non- self- replicating RNA). also method for administering subject achieve production encoded provide, example, prophylactic therapeutic passive immunity.

参考文章(30)
Ingmar Hoerr, Jochen Probst, Steve Pascolo, Rna-coded antibody ,(2008)
Michelle Chan, Manmohan Singh, Luis Brito, Derek O'hagan, Andrew Geall, Oil-in-water emulsions that contain nucleic acids ,(2012)
Steven R. Kain, Methods and protocols. Methods of biochemical analysis. ,vol. 47, pp. 407- 421 ,(2005) , 10.1002/0471739499.OTH1
Christian Mandl, Armin Hekele, Andrew Geall, Self replicating rna molecules and uses thereof ,(2010)
Mariola Fotin-Mleczek, Kai Zanzinger, Regina Heidenreich, Christina Lorenz, Andreas Thess, Katharina M. Duchardt, Karl-Josef Kallen, Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect Journal of Gene Medicine. ,vol. 14, pp. 428- 439 ,(2012) , 10.1002/JGM.2605
Michael W. Heartlein, Douglas Treco, Richard F Selden, In vivo production and delivery of erythropoietin for gene therapy ,(1995)
Michael W. Heartlein, Douglas Treco, Richard F Selden, In vivo protein production and delivery system for gene therapy ,(1994)
Christopher Hank Becker, Thomas Andrew Shaler, Daniel Joseph Pollart, Joseph Albert Monforte, Oligonucleotide sizing using immobilized cleavable primers ,(1995)